Ignite Creation Date:
2025-12-25 @ 3:57 AM
Ignite Modification Date:
2026-01-27 @ 5:08 AM
Study NCT ID:
NCT00518102
Status:
COMPLETED
Last Update Posted:
2016-07-19
First Post:
2007-08-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Risk of Cancer in Users of Regranex (Becaplermin) and Matched Comparators (Nonusers of Regranex [Becaplermin])
Sponsor:
Ethicon, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Diabetes Mellitus | View |